a hi Oa cD 0 n.j U, to N t cJ C tO C (U U x Is tO (U [PDF]

SLIDE 1

r

hiOa n.j Lt} N tO (U

a

>z — t C to cJ C U cD n.j U, N tO (U x Is tO (U (U

a

SLIDE 2

Prescribed Opioids

Codeine

(only

available

in

generic f

r

m )

F

e n t a n y l

(Actiq,

D u r a g e s i c , Fentora)

Hydrocodone

(Hysingla ER, Zohydro

ER)

H

y d r

c
d
n

e / a c e t a m i n

p

h e n

(Lorcet, Lortab, Norco, Vicodin)

H

y d r

m
r

p h

n

e

(Diiaudid, Exalgo)

Meperidine

(Demerol)

M

e t h a d

n

e (Dolophine, Methadose)

Morphine (Astramorph,

Avinza, Kadian, MS Contin,

Ora-Morph

SR)

Oxycodone

(OxyContin, Oxecta, Roxicodone)

Oxycodone and acetaminophen (Percocet,

Endocet, Roxicet)

O

x y c

d
n

e a n d naloxone

(Targiniq ER)

FERRER POIROT WANSBROUGH ill,, CnLtI n,i,nII,

The Opioid Epidemic

FEARS NACHAWATI

I. A W F I Ii M 4..

/

4

I

.

t

2

SLIDE 3

Opioid Addiction

I m p a c t

By

t h e _ N u m b e r s

About one third is from higher health care and addiction

treatment costs people daily

580

initiate heroin use

7S

people die every day from overdose

6

O u t

Drug Overdose

deaths involve an Americans have died from drug

verdose in the

last 17 years.

Source: National center for Injury Prevention and Control, CDC

![!REI POIROT

WAHSBRDUGH

ii lb.., I.,HI.

The Oplaid Epidemic

FEARS NACFL4WATI

I. A W F I P IA

estimate of the economic burden of the epidemic to the country in 2013.

650,000

pioid

prescriptions dispensed daily

$ 7 8 . 5 B i l l i

n

$28.9 Billion $20 B i l l i

n
f

10

pioid.

in lost productivity in nonfatal cases.

500,000

Of non-working

31%

men in the prime

f their lives are

taking opioids

3

SLIDE 4

C”

H

I

‘

Probability of continuing use (96) QtflO

ttlOtfl

Otfl

OLn

t—.— I I I I I I I I I I

I

III

r

4%

—

—.

I 4’

m

I

— :

3,

gg

I

— C

I

Oj

4%

“

t

—.

—.

‘-3

a

tic 3 —. I

z

I

a

n

I

______

tic

Z

“Ii tTI — F

Eji

C

SLIDE 5 Lfl

r

CJ

S

4.’

(U

a) a)

vi

ø

a)

‘I

2’

01

a)

1...

a) a) I

a)

I-

CD-S taj C0 a Ln Ln S — U, Co 0)

bo°

U

E Coo,

x._

0)—.

S

cE

0)0 ctCt —0)

00

& >-o

a-o

a_C.

QO

0-c

uc

In

tic

.2

CD

N n N C4 C N C C N C C N N

g

N C C e

e

C
C
6

C U’ N —

SLIDE 6 ; C f l ’ n i

C—

r

a

Accidenwi O D s p e r 1 .

%J C C

h

C

a

_ _ X

a

J

____

.
c

‘4

—

Og— _ _ _

C-.. a

_ _ ___

1

( S c

U

_________ O

I t

.4c:dzr

r

a

______________

d

______________

II

_______________

*1

a

___________________________________

a

ri-I *

:

C.’

SLIDE 7 —v

cc

deaths per 100,000

10 15 20

25 30

I I I I I Ni

C

I

N

I

C-

g

/

(3,

I

ID Ni

/

‘I)

/

&
i

n

/

I

—
—

a z N . Ct

e

0. —

k

t

— —---— __________ I e e —

deaths per 100.000 200 250 300 350 400

450 I I to. — CD — ci,

B

C

t

CD I)

2

H1

tij

P3 tJ1 Ui t..a > C

>

corn C m u

z

co

I

J

SLIDE 8 So,ncc: I,,wr,j,nionai A,,rouc.c C

n

, m I horny. counesv

f

Unircrsitv

f

JJ’tcconsin Pain a n d Pniin S t u d i e s G m u p FERR

[ I I

P01 ROT

W A N S E R O U C K

‘dli, Qinel ‘Liii Iii.

The Opioid Epidemic

FEARS NACHAWATI

t A W F I P M 60.000

Oxycodone consumption,

2015

I n

kilograms

— ——— 20. 000 _e C? ‘?

—

S

SLIDE 9 250

200

5

Sources:

I n t e r n a t i

n

a l N a r c

t

i c s Control B

a

r d ; W

r

l d Health Organization p

p

u l a t i

n

data By: Pain & P

l

i c y S t u d i e s Otoup. University

f

Wisconsin/WHO C

l

l a b

r

a t i n g C e n t e r . 2 1 8

e

Europe ( E U R O )

x

y c

d
n

e

.

U S A

x

y c

d
n

e F E R R E R PUIROT

WANSRbUGII

e..h,h A N.

The Opioid Epidemic

PEARS NACHAWATI

I. A W F I P M

W

r

l d

O x c

d
n

e C

n

s u m p t i

n

1 9 8

2

1 5

a-

eape,->c...c.o

9

SLIDE 10

C C

w

q

!.

.a.

—•

Qi

€

VI

:2

‘a

C

4-

VI

0)

4-’

U

C

CD

ci

i

C

C)

C

I

.1 S S I S e .

1

o

‘—‘ U).

=

U

=

0.

03

9 5 C

1-s

r

SLIDE 11

0)

1—’

D C

Os-

—C)

Cu

C

Lflro

b.O

0)0)

—

(/)

_0

a

—

C

—

41

1.

a

‘I.

UI

4.J

Lfl

..

a)

too-

—

F-02

1.C

I—

.o

N

Em

a

,0

E

0)

—

F-co

0)

to-’

C

—

e

—l

SLIDE 12

‘ I , < 1

S

=

Ct — = I , —

a ,

“ U —

—

— —s _4Ll_ as — , , U a, — Lu , 4 w

.

s t sz

U,

S

ciD ‘

0.

IP

sq

E

C

=

2

I

C

:

C I ,

;4C

=

2

a )

ii

D

2

U

SLIDE 13

m

a,.

1..

(a

>..

C

E

4-I

C

LI) LI)

a) I

b.C

C

I-)

.E E

a)

SC

.3

w

1

C

u1

m

I

e 1 I

e

I

OOj
-.

taJ COE a

.2

4-’

U

C

9

SLIDE 14

D

C

=

C

=

C

.2

E

.2

—

00

=

I-

In

0)

Wi

C

E

Lu

.4_a U 0.

w Lu

U

C

—

—

0)

it

—

U

>1

E

5

t t

I-

C

0)

t

VI

U-

&

d

4.0

0)

2

C

. E E

U

a)

C

In I..

I—

LL

I

b.O

C

‘I. +

4_a

C

a),

In

1

0)

ft C

I—

V

‘UI

U.

I-

.

O

u

w

It

a)

C

en

.2

bOt

— —

Wi

wxEnt

O.W

tuft

=

.

I

It

I

3

ft

a

SLIDE 15 Lfl 4-J

0)

CD

C

CD

U)

4-’

a

4-’ U)

13

a)

U)

S

(1)

a

I

.1 e I I S S S

I

I-

a.

LaJ Cfla I_I La— a 4- Ci us

z

in

vi w

UI

SLIDE 16

Its Getting_Better, Right?

Jonathan

N

v

a k ,

p a r t

f
ur litigation team

w a s

f e a t u r e d

n

b

t

h

60

M i n u t e s and

a

r e c e n t explained

t h a t

a t

t h e height

existing regulations,

P

l

i t i c a l

pressure from

n

high

e n d e d

DEA

enforcement.

T

h e Marino

Act

finalized

t h e

efforts

n

b e h a l f

f

t h e drug and distributors

by

r e m

v

i n g

t e e t h ,

e f f e c t i v e l y

stripping t h e

DEA

f

their enforcement

ability.

Leaving
nly

t h e

Civil

justice

System to hold

t h e m a c c

u

n t a b l e

FERRER POIROT WANSBROUGH O.•J.I lbn,, Ii..iII.

The Opioid Epidemic

FEARS NACHAWATI

LAW FIRM

enforce S e n a t e Hearing

f

the they

DEA’s

efforts were s h u t down.

m a n u f a c t u r e r s the

DEA’s

16

SLIDE 17

d1

Ucr

crew,

tu

U,

cj

.4_i

Ln

5

C —r

u

cuD

t

D

Q4J%_4J

co

uun-’c

L

suG)

C

J 8

6b

.,
E

tn

C U

5 50 D

a. a.

— N 4_i

D

4-’

L

U

<or

C

.2

4-’

F

S S S S S

.

CD

cc:

taJ L1

U

C

(0

Ut)

D

z

U

c

a

. . .

.

. .

.

B B B

SLIDE 18

Damages

Actual

D a m a g e s

Cost of

indigent care

Cost of any County

supported drug relief

L

a w

enforcement

cost, jails

L

i t i g a t i

n

cost

Punitive

D a m a g e s

E

x e m p l a r y

d a m a g e s

( g r

s

s n e g l i g e n c e )

T

r e b l e

d a m a g e s

E

q u i t a b l e relief ( a n d

t h e costs

f

t h e equitable

relief)

Injunction
Abatement
Attorney’s

f e e s

FERRER POIROT

The Opioid Epidemic

— — — — — — WANSBR0(JOH Jk. OIIkJ huT

FEARS NACHAWATI

I A W F I A M—-—

18

SLIDE 19 0,

‘a

C

z

U

In

3%

(5

.

‘a

vi

(0

ci)

>

ci)

a

S

4J

C D

U

a)

4J

C C

U,

L..

ci)

a

0)

a

C C

U

>

x

U,

a

(N In

U,

>

C

(0

S

U,

I

Cl) (-‘.4 S S S e S

e

‘_.

C Ia-I =

=

Ia-i!

a

I

SLIDE 20

In

n.j S ‘SD, C,., 0,

I

r4

I

E

‘4-

C)

41

(5

C)

In

V

I..

C)

‘I

bO

1

>%

4-’

C

z

In

3%

I-

(5

4-’

vi

It’ It’

\

‘S

\

‘S

C

La

E

S.

U U

cij

c

3J

E

4-

U,

r

4-J

E

S...

4-

C) In S.. a)

> >,

.0

c

4J 10

a)

CU,

4-v-

00

CI

Ci

InC

Wa”

U0”

(/D S S e S

.

CD =
0!

—J

SLIDE 21 C CD LI-i LIZ a

LI-

a ni

C

LI S S S e

e

C

.2

4.,

U

UI

—

C

.2

‘I U

SE

C

4.,

a)

E

U,

SD

a)

t

a)

U,

C

.2

4.,

a

a)

4.,

to

LU

“2
£

..,

%J ‘L-

in

Os

a)

41

U)

4-.

‘C

a)

2

SLIDE 22 r%J

z

U ,

a )

E

a )

C

I-

: 9

m

Co

a)

CI)

C

a

a

4

a)

I

a .

E

.i

U

. 5

a)

4’

a )

C

U

ci

a

D — U, C — C)

tø

Ct

U

— U, . ‘ U, C

z

C

C

— (V

.

—

t

—

.

:9

CV >, D >

t

> (V z _ ,

_

It

4

eq di

z

2

di

z

t

(0

H .

— 2

C) . 1 ) > ;;%

:

LJJ (fl LU

SLIDE 23 m

d

.2

4-’ CC 4-’ .— — ‘C

9

W

—

0.

E

V

C

CC

.cc

c0

0’

a0

tao

4.I

IØ

00

4J3-’

CC

C

>0

WE

C

0CC

CCV

0>

CC

10

4-i

V

z

0.

W

‘I .4-i

U

W

t

tao

0i

04-i WV

CC0

CII

04-i

C.—

CCV

4-i

U

tCC

—CC CCC

CO

U

in

4-i

WV

I-

E

U

I-

C

.2

4-i Cu 4-i 43 4-, CC

U

0CC ‘no

CC

CC0

F

C

I

4-i 4-i CC >1 CC

C

0>

Co

—U

_W CC

.0

C

CC

Win

Eu)

is

Q$C

CO

WV

b.OL.

Co

4-ill)

CO

OW V’I

CC

C

CC

V

CC S S e S S

e

Cc:

“a 3

SLIDE 24 n.j

2

.

bO

1111k

w0

>1

00

0)

C

0)0

Eo

4•••

O.

4-’

ObO

LX

<

U..(D

S

(U

‘I

z

C

(a

C

4.,

(U

C

i

4-’

U

z

V

C

U

4-’

In

0)

2

U 0)

II

N

c%4

0)

.0

2

0)

‘I

z

as

0)

4-’

C

0)

LI)

0) SC

4-’

0)

I

Is

00:

0- r u-I to 2 LI.J

2

SLIDE 25 U, n.j

41

CU CD

U

CU

2

In

CU

a)

C

CD 41

—
J

U

—

41

a) U

CD

E

1

CD

C

a

a)

U

C

a)

I

a)

0.

LU ‘4—

In

CD

w

Lfl

t

C

CD CD .4-I

U)

4-I

I

a a

z

U,

e

In

a)

C

.4-I 4-I

+

ci

In

C

4-I CD

.ao

4-I

J

U

4-I

a)

U

CD

E

I-

CD

C

a

‘C

a

E

U

a)

to

L.. CD

J

C

U,

C

:

U,

a-

.2-

C

U,

I

a)

CD

a)

J
V

C

In

a) a)

C

4.,

U

tO

C

CD

C

—

CD

U

.— 4-’ I— 4-I CD

U

CD 4-’

E

I-

CD

C

a)

E

I

V

I

a)

a)

z

In

U

I- CD

=

a)

‘4-

w
C

4-I

I;

S S S S

o

‘—I

U—

SLIDE 26

Ferrer Poirot & Wansbrough

16 Attorneys, 100+ Support Staff, 37 years of Experience in Pharmaceutical Litigation

Numerous Leadership Positions in Large Complex Pharmaceutical Litigations Hundreds of Millions of Dollars Recovered From Pharmaceutical Manufacturers Past Success Ensures the Resources Needed for See this litigation through to the end

FERRER rornoT WANSBROUGH ‘I

The Opioid Epidemic

FEARS NACHAWATI

L A W F I Ii M

26

SLIDE 27

9

C tJ C U C, 4. 1i V N n.j a,, n.J In N In cv U

O3b

13

cD (N In N U, cv x CM cv cv

U